August 6, 2026
Is Your Clinical Trial at Risk: When to Consider a Rescue Strategy
Identify the warning signs of a clinical trial at risk and learn when to implement a structured rescue strategy to ensure study success and data integrity.
ProPharma offers global Clinical Quality Assurance consulting to ensure inspection readiness and regulatory compliance across pharmaceutical, biologics, and medical device sectors. Our experienced QA professionals deliver end-to-end support—from GCP audits, SOP development, and CAPA management to trial oversight and mock inspections—tailored to your needs in every region. Wherever your clinical programs operate, we help you maintain quality, integrity, and confidence.
A strong Clinical Quality Assurance (CQA) framework is essential for maintaining the integrity, reliability, and compliance of clinical programs. Our CQA services provide proactive to reactive quality support to sponsors and CROs, ensuring adherence to regulatory standards and industry best practices. Ensure Clinical Quality & Compliance with Expert Support.

Oversight and compliance support for CROs, investigator sites, central labs, pharmacies, animal/toxicology studies, SaaS providers, and other vendors to ensure regulatory adherence and performance.
Identifying and resolving clinical trial issues to mitigate risks and improve study outcomes.
Thorough assessments of Trial Master Files to ensure completeness, accuracy, and regulatory compliance.
Tailored support to address specific clinical quality challenges and operational needs.
A structured auditing approach is essential for identifying compliance gaps, mitigating risks, and ensuring regulatory readiness. Our clinical auditing services help organizations maintain compliance with global regulatory expectations.
Regulatory inspections can be complex and high-stakes. Our inspection readiness services ensure your organization is fully prepared to meet global regulatory expectations with confidence.
A well-structured Clinical Sponsor Quality Management System (QMS) is essential for regulatory compliance, operational efficiency, and risk mitigation. At ProPharma, we help sponsors design, implement, and optimize QMS frameworks tailored to their clinical study and organizational needs.
The process begins with a kick-off meeting to ensure alignment with our client and key stakeholders to review unique requirements to consider.
Moving into the execution phase, we assess and implement QMS improvements:

Evaluating your current QMS and scaling solutions to fit your organization’s size, scope, and regulatory requirements.
Creating and refining policies, SOPs, and quality documents to ensure compliance with industry standards.
Supporting the seamless integration of quality management systems across your operations.
Providing in-depth training on QMS best practices, regulatory expectations, and continuous improvement strategies.
Whether you're building a new QMS or enhancing an existing system, our experts provide tailored solutions to ensure compliance and efficiency.
At ProPharma, we provide expert clinical consulting services to medical device and diagnostics companies. Helping to navigate and ensure compliance to complex global regulatory requirements while achieving operational excellence.
Our team specializes in supporting the unique requirements of medical device companies in meeting international compliance standards, including:
Partner with us for expert clinical compliance and quality solutions. Contact ProPharma today to learn how we can support your organization's Clinical Quality Assurance needs.
August 6, 2026
Identify the warning signs of a clinical trial at risk and learn when to implement a structured rescue strategy to ensure study success and data integrity.
August 5, 2026
FDA's QMSR is now in effect. Learn the seven most common quality system gaps medical device manufacturers should assess to prepare for FDA inspections and achieve QMSR compliance.
July 8, 2026
ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.
June 18, 2026
ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.
January 31, 2025
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
August 3, 2026
Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...
July 23, 2026
As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...
July 15, 2026
Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...
September 30, 2026
Clinical trial delays often begin long before study conduct, with critical decisions made during feasibility and study start-up shaping the success of the entire trial. Join this webinar to discover...
June 4, 2026
Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...
August 3, 2026
Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...
July 23, 2026
As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...
July 15, 2026
Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...